Creary Lab
The Creary Lab, led by Susan Creary, MD, MSc, focuses on improving outcomes of children, adolescents and young adults with sickle cell disease (SCD). SCD is an inherited condition that primarily affects underrepresented minority populations. Dr. Creary's research interests are to improve effective use of existing therapies for this population and to empower individuals with SCD and their families to make informed decisions about their health. Dr. Creary receives funding from the National Institutes of Health, National Heart, Lung and Blood Institute and the Agency for Healthcare Research and Quality for her research in SCD.
Featured Research Projects
NHLBI funded, multi-site, pilot randomized trial of an innovative strategy (video directly observed therapy) to improve hydroxyurea adherence among children and adolescents with SCD.
A study to develop a web-based reproductive education program and evaluate if it improves knowledge among adolescent males with SCD and their caregivers. This study is also evaluating strategies to do fertility testing in adolescent males with SCD.
Dr. Creary uses large databases to evaluate the use of disease modifying therapies for SCD and to identify the reproductive health care gaps and outcomes of adolescents and young adults with SCD.
